🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Fostering Data Sharing

Search Papers Authors Institutions Grants FAIR About

TheSindex

Fostering Data Sharing

Empowering the data sharing that empowers science — an open, citation-grounded index for datasets.

Product

Search
API
Explore
Rankings

Resources

Methodology
Data Sources
Documentation
Press

Organization

About
Team
Wikidata

© 2026 theSindex. All rights reserved.

Home
Authors
Isabelle Rivière

Isabelle Rivière

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent Pembrolizumab”.

A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent Pembrolizumab

Cancer Discovery(2021)10.1158/2159-8290.cd-21-0407

N/A

0DataRank · unranked

570 citations

Marjorie G. Zauderer, Isabelle Rivière, Stephen B. Solomon, Valerie W. Rusch, Roisin E. O’Cearbhaill +25 more

Preclinical Efficacy and Safety of a Human Embryonic Stem Cell-Derived Midbrain Dopamine Progenitor Product, MSK-DA01

Cell stem cell(2021)10.1016/j.stem.2021.01.004

N/A

0DataRank · unranked

256 citations

Susan E. Zabierowski, Brittany N. Dubose, Ellen J. Hill, Monalisa Navare, Nidia Claros +19 more

HLA-independent T cell receptors for targeting tumors with low antigen density

Nature Medicine(2022)10.1038/s41591-021-01621-1

N/A

0DataRank · unranked

185 citations

Justin Eyquem, Sascha Haubner, Mohamad Hamieh, Judith Feucht, Noémie Paillon +20 more

CD19-directed chimeric antigen receptor T cell therapy in Waldenström macroglobulinemia: a preclinical model and initial clinical experience

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-004128

N/A

0DataRank · unranked

36 citations

David Qualls, Sébastien Monette, Shenon Sethi, Ahmet Doǧan, Mikhail Roshal +8 more

Replication competent retrovirus testing (RCR) in the National Gene Vector Biorepository: No evidence of RCR in 1,595 post-treatment peripheral blood samples obtained from 60 clinical trials

Molecular Therapy(2022)10.1016/j.ymthe.2022.12.006

N/A

0DataRank · unranked

11 citations

Jing Yao, Kimberley House, Lisa Duffy, Prasad S. Adusumilli, Rachel K. Beyer +26 more

CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results

Nature Medicine(2023)10.1038/s41591-023-02404-6

N/A

0DataRank · unranked

167 citations

Karthik Nath, Sean M. Devlin, Craig S. Sauter, M. Lia Palomba, Gunjan L. Shah +14 more

Cooperative CAR targeting to selectively eliminate AML and minimize escape

Cancer Cell(2023)10.1016/j.ccell.2023.09.010

N/A

0DataRank · unranked

113 citations

Jorge Mansilla‐Soto, Sarah Nataraj, Friederike Kogel, Qing Chang, Elisa de Stanchina +9 more

Validation of a High-Sensitivity Assay for Detection of Chimeric Antigen Receptor T-Cell Vectors Using Low-Partition Digital PCR Technology

Journal of Molecular Diagnostics(2023)10.1016/j.jmoldx.2023.06.002

N/A

0DataRank · unranked

3 citations

Utsav Patel, Amir Momeni Boroujeni, JinJuan Yao, Roger Chan, Joe Chan +18 more

Calibrated CAR Signaling Enables Low-Dose Therapy in Large B-Cell Lymphoma

Research Square(2024)10.21203/rs.3.rs-4619285/v1

N/A

0DataRank · unranked

2 citations

M. Lia Palomba, Karlo Perica, Sean M. Devlin, Gunjan L. Shah, Parastoo B. Dahi +28 more